Arkema SA (OTCMKTS:ARKAY – Get Free Report) has earned a consensus rating of “Reduce” from the seven brokerages that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating on the company.
Separately, Barclays upgraded Arkema from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 12th.
View Our Latest Analysis on ARKAY
Arkema Trading Down 0.4%
Shares of ARKAY opened at $61.96 on Friday. The stock’s fifty day simple moving average is $64.65 and its 200-day simple moving average is $66.84. The company has a quick ratio of 1.08, a current ratio of 1.52 and a debt-to-equity ratio of 0.42. Arkema has a 12-month low of $56.28 and a 12-month high of $79.36. The firm has a market capitalization of $4.71 billion, a PE ratio of 213.66 and a beta of 0.88.
Arkema (OTCMKTS:ARKAY – Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The basic materials company reported $1.98 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.12. The company had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.86 billion. Arkema had a return on equity of 4.30% and a net margin of 0.67%. As a group, research analysts predict that Arkema will post 3.73 earnings per share for the current year.
Arkema Company Profile
Arkema is a France-based global specialty materials company that develops and manufactures products used in a wide range of industrial and consumer applications. Its portfolio includes specialty adhesives, high-performance polymers, acrylic materials, coating resins, additives and other chemical solutions designed to improve durability, performance and sustainability.
The company operates through businesses focused on Adhesive Solutions, Advanced Materials and Coating Solutions. Its products serve markets such as construction, automotive, electronics, packaging, renewable energy, consumer goods and industrial manufacturing.
Featured Stories
- Five stocks we like better than Arkema
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
